Michael J. Hansen

3.1k total citations · 1 hit paper
46 papers, 1.8k citations indexed

About

Michael J. Hansen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Michael J. Hansen has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 15 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Michael J. Hansen's work include CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (11 papers) and Virus-based gene therapy research (8 papers). Michael J. Hansen is often cited by papers focused on CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (11 papers) and Virus-based gene therapy research (8 papers). Michael J. Hansen collaborates with scholars based in United States, Denmark and Germany. Michael J. Hansen's co-authors include John G. Flanagan, Neal G. Copeland, Gaël McGill, Heinz Arnheiter, Timothy J. Hemesath, Colin A. Hodgkinson, David E. Fisher, Eirı́kur Steingrı́msson, N.A. Jenkins and Gerard E. Dallal and has published in prestigious journals such as Nature Communications, Neuron and Genes & Development.

In The Last Decade

Michael J. Hansen

44 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.

1994 547 citations Michael J. Hansen et al. profile →

Peers

Michael J. Hansen

CMN

IMMUN

GENET

Sarah J. Heasman United Kingdom

Deni S. Galileo United States

Francina Langa France

Ming‐Ming Jiang United States

Ermelinda Porpiglia United States

Ichiko Saotome United States

E Chabrol France

Hiroyoshi Ishizaki Japan

Paul L. Kaplan United States

Frances A. Lemckert Australia

Sarah J. Heasman United Kingdom

Michael J. Hansen

1.2k ×1.5

718 ×1.3

215 ×0.5

CMN

359 ×0.9

IMMUN

131 ×0.5

GENET

Citations per year, relative to Michael J. Hansen Michael J. Hansen (= 1×) peers Sarah J. Heasman

Countries citing papers authored by Michael J. Hansen

Since Specialization

Citations

This map shows the geographic impact of Michael J. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Hansen more than expected).

Fields of papers citing papers by Michael J. Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Hansen. The network helps show where Michael J. Hansen may publish in the future.

Co-authorship network of co-authors of Michael J. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Hansen. A scholar is included among the top collaborators of Michael J. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Hansen. Michael J. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jenkins, James W., Michael J. Hansen, Virginia P. Van Keulen, et al.. (2025). MHC class II-mediated spontaneous rejection of breast carcinomas expressing model neoantigens. Journal for ImmunoTherapy of Cancer. 13(4). e010434–e010434. 2 indexed citations

Ayasoufi, Katayoun, Courtney S. Malo, Benjamin Himes, et al.. (2023). Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression. Cancer Immunology Research. 11(6). 763–776. 1 indexed citations

Massey, Shane, Michael J. Hansen, Courtney L. Erskine, et al.. (2022). Comparison of replicating and nonreplicating vaccines against SARS-CoV-2. Science Advances. 8(34). eabm8563–eabm8563. 9 indexed citations

Park, Walter D., et al.. (2022). Liver mesenchymal stem cells are superior inhibitors of NK cell functions through differences in their secretome compared to other mesenchymal stem cells. Frontiers in Immunology. 13. 952262–952262. 10 indexed citations

Hansen, Michael J., et al.. (2021). Flow Assisted Mutation Enrichment (FAME): A highly efficacious and efficient method to enrich Double Knockouts (DKO) after gene editing. PLoS ONE. 16(3). e0247375–e0247375. 1 indexed citations

Hansen, Michael J., et al.. (2021). Modulating Oncolytic Adenovirus Immunotherapy by Driving Two Axes of the Immune System by Expressing 4-1BBL and CD40L. Human Gene Therapy. 33(5-6). 250–261. 7 indexed citations

Malo, Courtney S., Katayoun Ayasoufi, Cori E. Fain, et al.. (2020). Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen–Specific CD8 T Cell Responses during Theiler's Virus Infection. The Journal of Immunology. 205(5). 1228–1238. 7 indexed citations

Sakemura, Reona, Michelle J. Cox, Mehrdad Hefazi, et al.. (2020). Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma. Biology of Blood and Marrow Transplantation. 26(3). S224–S224. 1 indexed citations

Malo, Courtney S., Roman H. Khadka, Katayoun Ayasoufi, et al.. (2018). Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental Glioma. Frontiers in Oncology. 8. 320–320. 37 indexed citations

10.

Malo, Courtney S., Matthew A. Huggins, Emma N. Goddery, et al.. (2018). Non-equivalent antigen presenting capabilities of dendritic cells and macrophages in generating brain-infiltrating CD8 + T cell responses. Nature Communications. 9(1). 633–633. 34 indexed citations

11.

Hansen, Michael J., et al.. (2015). Folate receptor expression on murine and human adipose tissue macrophages. Inflammation Research. 64(9). 697–706. 6 indexed citations

12.

Pavelko, Kevin D., Yanice Mendez-Fernandez, Michael P. Bell, et al.. (2012). Nonequivalence of Classical MHC Class I Loci in Ability to Direct Effective Antiviral Immunity. PLoS Pathogens. 8(2). e1002541–e1002541. 6 indexed citations

13.

Trobridge, Grant D., R. Alex Wu, Michael J. Hansen, et al.. (2009). Cocal-pseudotyped Lentiviral Vectors Resist Inactivation by Human Serum and Efficiently Transduce Primate Hematopoietic Repopulating Cells. Molecular Therapy. 18(4). 725–733. 51 indexed citations

14.

Kantor, David B., Onanong Chivatakarn, Katherine L. Thompson-Peer, et al.. (2004). Semaphorin 5A Is a Bifunctional Axon Guidance Cue Regulated by Heparan and Chondroitin Sulfate Proteoglycans. Neuron. 44(6). 961–975. 310 indexed citations

15.

Block, Matthew S., Michael J. Hansen, Virginia P. Van Keulen, & Larry R. Pease. (2003). MHC Class I Gene Conversion Mutations Alter the CD8 T Cell Repertoire. The Journal of Immunology. 171(8). 4006–4010. 8 indexed citations

16.

Mendez-Fernandez, Yanice, Matthew S. Block, Aaron J. Johnson, et al.. (2002). Enhanced binding of low‐affinity antibodies interacting simultaneously with targeted cell surface molecules and Fc receptor. Tissue Antigens. 60(6). 515–525. 2 indexed citations

17.

Cherington, Van, Gisela G. Chiang, Theofanis Galanopoulos, et al.. (1998). Retroviral Vector-Modified Bone Marrow Stromal Cells Secrete Biologically Active Factor IX In Vitro and Transiently Deliver Therapeutic Levels of Human Factor IX to the Plasma of Dogs after Reinfusion. Human Gene Therapy. 9(10). 1397–1407. 33 indexed citations

18.

Emami, Shahin, Van Cherington, Gisela G. Chiang, et al.. (1997). Enhanced growth of canine bone marrow stromal cell cultures in the presence of acidic fibroblast growth factor and heparin. In Vitro Cellular & Developmental Biology - Animal. 33(7). 503–511. 6 indexed citations

19.

Hansen, Michael J., et al.. (1994). The ompA 5′ untranslated region impedes a major pathway for mRNA degradation in Escherichia coli. Molecular Microbiology. 12(5). 707–716. 70 indexed citations

20.

McDermott, John Francis, et al.. (1975). Interviewing, motivation, and clinical judgment. Academic Medicine. 50(2). 192–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact